These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 6146667)

  • 1. Investigation on central dopaminergic receptors (D-2) using the antagonistic properties of new benzamides.
    Rumigny JF; Strolin Benedetti M; Dostert P
    J Pharm Pharmacol; 1984 Jun; 36(6):373-7. PubMed ID: 6146667
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Potential antipsychotic agents. 9. Synthesis and stereoselective dopamine D-2 receptor blockade of a potent class of substituted (R)-N-[(1-benzyl-2-pyrrolidinyl)methyl]benzamides. Relations to other side chain congeners.
    Högberg T; Ström P; de Paulis T; Stensland B; Csöregh I; Lundin K; Hall H; Ogren SO
    J Med Chem; 1991 Mar; 34(3):948-55. PubMed ID: 1672158
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Potential antipsychotic agents. 7. Synthesis and antidopaminergic properties of the atypical highly potent (S)-5-bromo-2,3-dimethoxy-N-[(1-ethyl-2-pyrrolidinyl)methyl]benzamide and related compounds. A comparative study.
    Högberg T; de Paulis T; Johansson L; Kumar Y; Hall H; Ogren SO
    J Med Chem; 1990 Aug; 33(8):2305-9. PubMed ID: 1973734
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of lipophilicity of substituted benzamides on the dopaminergic effects in vivo and in vitro.
    Hall H; Ogren SO; Florvall L
    Acta Pharmacol Toxicol (Copenh); 1984 Sep; 55(3):211-5. PubMed ID: 6542298
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Studies on the mechanism of action of substituted benzamide drugs.
    Köhler C; Ogren SO; Fuxe K
    Acta Psychiatr Scand Suppl; 1984; 311():125-37. PubMed ID: 6142588
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Septo-hippocampal system: target for substituted benzamides.
    Bischoff S; Bittiger H; Delini-Stula A; Ortmann R
    Eur J Pharmacol; 1982 Apr; 79(3-4):225-32. PubMed ID: 7201401
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis and binding properties of the fluorinated substituted benzamide [3H]NCQ 115, a new selective dopamine D2 receptor ligand.
    Hall H; Högberg T; Halldin C; Bengtsson S; Wedel I
    Eur J Pharmacol; 1991 Aug; 201(1):1-10. PubMed ID: 1686586
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Definition of the in-vivo binding of [3H]spiperone in rat brain using substituted benzamide drugs.
    Chivers JK; Reavill C; Jenner P; Marsden CD
    J Pharm Pharmacol; 1989 Feb; 41(2):106-11. PubMed ID: 2568417
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antistereotypic effects of dopamine D-1 and D-2 antagonists after intrastriatal injection in rats. Pharmacological and regional specificity.
    Arnt J
    Naunyn Schmiedebergs Arch Pharmacol; 1985 Aug; 330(2):97-104. PubMed ID: 2864641
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Remoxipride, a new potential antipsychotic compound with selective antidopaminergic actions in the rat brain.
    Ogren SO; Hall H; Köhler C; Magnusson O; Lindbom LO; Angeby K; Florvall L
    Eur J Pharmacol; 1984 Jul; 102(3-4):459-74. PubMed ID: 6149133
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Substituted benzamides with conformationally restricted side chains. 2. Indolizidine derivatives as central dopamine receptor antagonists.
    King FD; Hadley MS; McClelland CM
    J Med Chem; 1988 Sep; 31(9):1708-12. PubMed ID: 2900897
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis and D2 dopaminergic activity of pyrrolidinium, tetrahydrothiophenium, and tetrahydrothiophene analogues of sulpiride.
    Harrold MW; Wallace RA; Farooqui T; Wallace LJ; Uretsky N; Miller DD
    J Med Chem; 1989 Apr; 32(4):874-80. PubMed ID: 2522993
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of remoxipride and some related new substituted salicylamides on rat brain receptors.
    Hall H; Sällemark M; Jerning E
    Acta Pharmacol Toxicol (Copenh); 1986 Jan; 58(1):61-70. PubMed ID: 2869639
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 2-Phenylpyrroles as conformationally restricted benzamide analogues. A new class of potential antipsychotics. 1.
    van Wijngaarden I; Kruse CG; van Hes R; van der Heyden JA; Tulp MT
    J Med Chem; 1987 Nov; 30(11):2099-104. PubMed ID: 2889830
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interaction of permanently uncharged dopamine analogs with the D-2 dopaminergic receptor.
    Wallace RA; Farooqui T; Wallace L; Ares J; Chang YA; Miller D; Uretsky N
    Biochem Pharmacol; 1988 May; 37(10):2077-84. PubMed ID: 2967702
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Selective labelling of dopamine (D2) receptors in rat striatum by [3H]domperidone but not by [3H]spiperone.
    Lazareno S; Nahorski SR
    Eur J Pharmacol; 1982 Jul; 81(2):273-85. PubMed ID: 7117377
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Substituted benzamides as cerebral dopamine antagonists in rodents.
    Elliott PN; Jenner P; Huizing G; Marsden CD; Miller R
    Neuropharmacology; 1977 May; 16(5):333-42. PubMed ID: 559256
    [No Abstract]   [Full Text] [Related]  

  • 18. Potent lipophilic substituted benzamide drugs are not selective D-1 dopamine receptor antagonists in the rat.
    Fleminger S; van de Waterbeemd H; Rupniak NM; Reavill C; Testa B; Jenner P; Marsden CD
    J Pharm Pharmacol; 1983 Jun; 35(6):363-8. PubMed ID: 6135774
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of calmodulin-dependent phosphorylation in chronic sulpiride-induced striatal dopamine receptor supersensitivity.
    Lau YS; Runice C; Dowd F
    J Pharmacol Exp Ther; 1984 Apr; 229(1):32-7. PubMed ID: 6323689
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multiple dopamine receptors in brain and the pharmacological action of substituted benzamide drugs.
    Jenner P; Marsden CD
    Acta Psychiatr Scand Suppl; 1984; 311():109-23. PubMed ID: 6142587
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.